Trends in Molecular Medicine,
Journal Year:
2023,
Volume and Issue:
29(8), P. 659 - 672
Published: June 22, 2023
Progression
of
Alzheimer's
disease
(AD)
entails
deterioration
or
aberrant
function
multiple
brain
cell
types,
eventually
leading
to
neurodegeneration
and
cognitive
decline.
Defining
how
complex
cell-cell
interactions
become
dysregulated
in
AD
requires
novel
human
cell-based
vitro
platforms
that
could
recapitulate
the
intricate
cytoarchitecture
diversity
brain.
Brain
organoids
(BOs)
are
3D
self-organizing
tissues
partially
resemble
architecture
can
AD-relevant
pathology.
In
this
review,
we
highlight
versatile
applications
different
types
BOs
model
pathogenesis,
including
amyloid-β
tau
aggregation,
neuroinflammation,
myelin
breakdown,
vascular
dysfunction,
other
phenotypes,
as
well
accelerate
therapeutic
development
for
AD.
Frontiers in Pharmacology,
Journal Year:
2019,
Volume and Issue:
10
Published: Sept. 12, 2019
Neurodegenerative
diseases
share
the
fact
that
they
derive
from
altered
proteins
undergo
an
unfolding
process
followed
by
formation
of
-structures,
and
a
pathological
tendency
to
self-aggregate
in
neuronal
cells.
This
is
characteristic
tau
protein
Alzheimer´s
disease
several
tauopathies
associated
unfolding,
synuclein
Parkinson
huntingtin
Huntington
disease.
Usually
self-aggregation
products
are
toxic
these
cells,
toxicity
spreads
all
over
different
brain
areas.
We
have
postulated
events
molecular
alterations
trigger
neurodegenerative
disorders.
Most
interestingly,
occur
as
result
neuroinflammatory
cascades
involving
cross-talks
between
glial
cells
neurons
consequence
activation
microglia
astrocytes.
The
model
we
hypothesized
for
disease,
involve
damage
signals
promote
activation,
NFβ
synthesis
release
proinflammatory
cytokines
such
TNF-,
IL1,
IL-6,
IL-12
affects
receptors
with
overactivation
kinases.
These
patterns
can
be
applied
In
this
context,
involvement
innate
immunity
seems
major
paradigm
pathogenesis
diseases.
important
element
search
potential
therapeutic
approaches
Aging Cell,
Journal Year:
2018,
Volume and Issue:
17(6)
Published: Aug. 20, 2018
Tau
protein
accumulation
is
the
most
common
pathology
among
degenerative
brain
diseases,
including
Alzheimer's
disease
(AD),
progressive
supranuclear
palsy
(PSP),
traumatic
injury
(TBI),
and
over
twenty
others.
Tau-containing
neurofibrillary
tangle
(NFT)
closest
correlate
with
cognitive
decline
cell
loss
(Arriagada,
Growdon,
Hedley-Whyte,
&
Hyman,
),
yet
mechanisms
mediating
tau
toxicity
are
poorly
understood.
NFT
formation
does
not
induce
apoptosis
(de
Calignon,
Spires-Jones,
Pitstick,
Carlson,
2009),
which
suggests
that
secondary
driving
toxicity.
Transcriptomic
analyses
of
NFT-containing
neurons
microdissected
from
postmortem
AD
revealed
an
expression
profile
consistent
cellular
senescence.
This
complex
stress
response
induces
aberrant
cycle
activity,
adaptations
to
maintain
survival,
remodeling,
metabolic
dysfunction.
Using
four
transgenic
mouse
models,
we
found
NFTs,
but
Aβ
plaques,
display
a
senescence-like
phenotype.
Cdkn2a
transcript
level,
hallmark
measure
senescence,
directly
correlated
atrophy
burden
in
mice.
relationship
extended
tissue
humans
PSP
indicate
phenomenon
mice
late-stage
were
treated
senolytics
remove
senescent
cells.
Despite
advanced
age
progression,
MRI
imaging
histopathological
indicated
reduction
total
density,
neuron
loss,
ventricular
enlargement.
Collectively,
these
findings
strong
association
between
presence
NFTs
senescence
brain,
contributes
neurodegeneration.
Given
prevalence
deposition
neurodegenerative
have
broad
implications
for
understanding,
potentially
treating,
dozens
diseases.
Ageing Research Reviews,
Journal Year:
2021,
Volume and Issue:
72, P. 101496 - 101496
Published: Oct. 22, 2021
Alzheimer's
disease
(AD)
is
the
most
prevalent
neurodegenerative
in
ageing,
affecting
around
46
million
people
worldwide
but
few
treatments
are
currently
available.
The
etiology
of
AD
still
puzzling,
and
new
drugs
development
clinical
trials
have
high
failure
rates.
Urgent
outline
an
integral
(multi-target)
effective
treatment
needed.
Accumulation
amyloid-β
(Aβ)
peptides
considered
one
fundamental
neuropathological
pillars
disease,
its
dyshomeostasis
has
shown
a
crucial
role
onset.
Therefore,
many
amyloid-targeted
therapies
been
investigated.
Here,
we
will
systematically
review
recent
(from
2014)
investigational,
follow-up
studies
focused
on
anti-amyloid
strategies
to
summarize
analyze
their
current
potential.
Combination
anti-Aβ
with
developing
early
detection
biomarkers
other
therapeutic
agents
acting
functional
changes
be
highlighted
this
review.
Near-term
approval
seems
likely
for
several
against
Aβ,
FDA
monoclonal
oligomers
antibody
–aducanumab–
raising
hopes
controversies.
We
conclude
that,
oligomer-epitope
specific
Aβ
implementation
multiple
improved
risk
prediction
methods
allowing
detection,
together
factors
such
as
hyperexcitability
AD,
could
key
slowing
global
pandemic.
Frontiers in Aging Neuroscience,
Journal Year:
2021,
Volume and Issue:
13
Published: Feb. 25, 2021
Aging
of
the
brain
can
manifest
itself
as
a
memory
and
cognitive
decline,
which
has
been
shown
to
frequently
coincide
with
changes
in
structural
plasticity
dendritic
spines.
Decreased
number
maturity
spines
aged
animals
humans,
together
synaptic
transmission,
may
reflect
aberrant
neuronal
directly
associated
impaired
functions.
In
extreme,
neurodegenerative
disease,
completely
devastates
basic
functions
brain,
develop.
While
cellular
senescence
peripheral
tissues
recently
linked
aging
aging-related
disorders,
its
involvement
is
just
beginning
be
explored.
However,
accumulated
evidence
suggests
that
cell
play
role
it
documented
other
organs.
Senescent
cells
stop
dividing
shift
their
activity
strengthen
secretory
function,
leads
acquisition
so
called
senescence-associated
phenotype
(SASP).
have
also
characteristics,
such
altered
morphology
proteostasis,
decreased
propensity
undergo
apoptosis,
autophagy
impairment,
accumulation
lipid
droplets,
increased
senescence-associated-β-galactosidase
(SA-β-gal),
epigenetic
alterations,
including
DNA
methylation,
chromatin
remodeling,
histone
post-translational
modifications
that,
consequence,
result
gene
expression.
Proliferation-competent
glial
both
vitro
vivo
,
they
likely
participate
neuroinflammation,
characteristic
for
brain.
apart
from
proliferation-competent
cells,
consists
post-mitotic
neurons.
Interestingly,
emerged
recently,
non-proliferating
present
or
cultivated
some
hallmarks,
SASP,
typical
senescent
ceased
divide.
It
senolytics,
by
definition,
eliminate
improve
ability
mice
models.
this
review,
we
ask
questions
about
impairments
how
senolytics
them.
We
will
discuss
whether
plasticity,
defined
morphological
functional
at
level
neurons
spines,
hallmark
susceptible
effects
senolytics.
Brain,
Journal Year:
2019,
Volume and Issue:
142(4), P. 1093 - 1107
Published: Feb. 4, 2019
In
Alzheimer's
disease,
tau
pathology
spreads
hierarchically
from
the
inferior
temporal
lobe
throughout
cortex,
ensuing
cognitive
decline
and
dementia.
Similarly,
circumscribed
patterns
of
pathological
have
been
observed
in
normal
ageing
small
vessel
suggesting
a
spatially
ordered
distribution
across
different
diseases.
vitro
findings
suggest
that
may
spread
'prion-like'
neuronal
connections
an
activity-dependent
manner.
Supporting
this
notion,
functional
brain
networks
show
spatial
correspondence
to
deposition
patterns.
However,
it
remains
unclear
whether
higher
network-connectivity
facilitates
propagation.
To
address
this,
we
included
55
aged
elderly
(i.e.
cognitively
normal,
amyloid-negative),
50
disease
patients
amyloid-positive)
covering
preclinical
dementia
spectrum,
as
well
36
with
pure
amyloid-negative)
vascular
impairment
due
disease.
All
subjects
were
assessed
AV1451
tau-PET
resting-state
MRI.
Within
each
group,
computed
atlas-based
MRI
connectivity
400
regions
interest
entire
neocortex.
Using
same
atlas,
also
within
group
covariance
levels
among
interest.
We
found
between
any
given
region
pair
was
associated
binding
corresponding
This
result
consistently
ageing,
impairment.
particular,
tau-hotspots,
defined
by
highest
uptake,
showed
high
predictive
value
functionally
closely
connected
These
associations
uptake
detected
regardless
presence
symptoms
(mild
or
dementia),
amyloid
(as
amyloid-PET)
Our
is
shared
tau-levels,
supporting
view
prion-like
spreading
facilitated
neural
activity.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(21), P. 12841 - 12841
Published: Oct. 25, 2022
Alzheimer’s
disease
(AD)
is
the
leading
cause
of
dementia
in
elderly
people.
Amyloid
beta
(Aβ)
deposits
and
neurofibrillary
tangles
are
major
pathological
features
an
brain.
These
proteins
highly
expressed
nerve
cells
found
most
tissues.
Tau
primarily
provides
stabilization
to
microtubules
part
axons
dendrites.
However,
tau
a
state
becomes
hyperphosphorylated,
causing
dysfunction
synaptic
impairment
degeneration
neurons.
This
article
presents
summary
role
tau,
phosphorylated
(p-tau)
AD,
other
tauopathies.
Tauopathies,
including
Pick’s
disease,
frontotemporal
dementia,
corticobasal
degeneration,
argyrophilic
grain
progressive
supranuclear
palsy,
Huntington’s
result
misprocessing
accumulation
within
neuronal
glial
cells.
also
focuses
on
current
research
post-translational
modifications
genetics
pathology,
tauopathies
development
new
drugs
targeting
p-tau,
therapeutics
for
treating
possibly
preventing
Frontiers in Synaptic Neuroscience,
Journal Year:
2023,
Volume and Issue:
15
Published: March 9, 2023
The
synapse
has
consistently
been
considered
a
vulnerable
and
critical
target
within
Alzheimer’s
disease,
loss
is,
to
date,
one
of
the
main
biological
correlates
cognitive
decline
disease.
This
occurs
prior
neuronal
with
ample
evidence
that
synaptic
dysfunction
precedes
this,
in
support
idea
failure
is
crucial
stage
disease
pathogenesis.
two
pathological
hallmarks
abnormal
aggregates
amyloid
or
tau
proteins,
have
had
demonstrable
effects
on
physiology
animal
cellular
models
There
also
growing
these
proteins
may
synergistic
effect
neurophysiological
dysfunction.
Here,
we
review
some
findings
alterations
what
know
from
models.
First,
briefly
summarize
human
suggest
synapses
are
altered,
including
how
this
relates
network
activity.
Subsequently,
considered,
highlighting
mouse
pathology
role
play
dysfunction,
either
isolation
examining
pathologies
interact
specifically
focuses
function
observed
models,
typically
measured
using
electrophysiology
calcium
imaging.
Following
loss,
it
would
be
impossible
imagine
not
alter
oscillatory
activity
brain.
Therefore,
discusses
underpin
aberrant
patterns
seen
patients.
Finally,
an
overview
key
directions
considerations
field
covered.
includes
current
therapeutics
targeted
at
but
methods
modulate
rescue
patterns.
Other
important
future
avenues
note
include
non-neuronal
cell
types
such
as
astrocytes
microglia,
mechanisms
independent
will
certainly
continue
for
foreseeable
future.
Aging and Disease,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 8, 2023
Alzheimer's
disease
(AD)
is
a
prevalent
neurodegenerative
characterized
by
both
amnestic
and
non-amnestic
clinical
manifestations.
It
accounts
for
approximately
60-70%
of
all
dementia
cases
worldwide.
With
the
increasing
number
AD
patients,
elucidating
underlying
mechanisms
developing
corresponding
interventional
strategies
are
necessary.
Hypotheses
about
such
as
amyloid
cascade,
Tau
hyper-phosphorylation,
neuroinflammation,
oxidative
stress,
mitochondrial
dysfunction,
cholinergic,
vascular
hypotheses
not
mutually
exclusive,
them
play
certain
role
in
development
AD.
The
cascade
hypothesis
currently
most
widely
studied;
however,
other
also
gaining
support.
This
article
summarizes
recent
evidence
regarding
major
pathological
their
potential
interplay,
well
strengths
weaknesses
each
implications
effective
treatments.
could
stimulate
further
studies
promote
more
therapeutic